Alzac       Capsules

Fluoxetine Hydrochloride 10mg                                                                                                     

 

Usage and indications:

  • Major Depressive Disorder
  • Obsessive Compulsive Disorder.
  • Bulimia Nervosa.
  • Panic Disorder, with or without agoraphobia, in adult patients

Dosage and administration:

  • Major Depressive Disorder: 20 mg/day increased after several weeks if insufficient clinical improvement is observed.

For adults a dose range of 20-60mg/day is recommended; with a maximum dose of 80mg/day.

For elderly a dose range of 20-40mg/day is recommended; with a maximum dose of 60mg/day.

  • Obsessive Compulsive Disorder: 20 mg/day increased after (several) weeks if insufficient clinical improvement is observed.

For adults a dose range 20-60mg/day is recommended; with a maximum dose of 80mg/day.

For elderly; a dose range of 20-40mg/day is recommended; with a maximum dose of 60mg/day. 

  • Bulimia Nervosa: 60mg once daily.   
  • Panic Disorder: 10mg once daily increased after 1 week if necessary to 20 mg in 2 flexible-dose.

Undesirable effects:

It may cause gastro-intestinal effects (nausea, vomiting, dyspepsia, diarrhea, constipation) anorexia with weight loss, headache, insomnia, dizziness, asthenia, hallucinations, convulsions, violent behavior, fever, sexual dysfunction, possible changes in blood sugar, hyponatremia,  urinary retention, sweating, cutaneous bleeding disorders, aplastic anaemia, pneumonia, hypersensitivity reactions including rash, urticaria, anaphylaxis, arthralgia, myalgia and photosensitivity.

Warnings and precautions:

  • Alzac used with extreme caution with:
  • pilepsy, cardiac disease, diabetes mellitus, angle closure glaucoma, hepatic impairment, renal impairment and concurrent electroconvulsive therapy, pregnancy and breast-feeding.
  • SSRIs not recommended for use in children and adolescent aged under 18 years
  • Abrupt withdrawal of SSRIs should be avoided.
  • Suicide/suicidal thoughts or clinical worsening:

Depression is associated with an increased risk of suicidal thoughts, self-harm and suicide (suicide-related events). This risk persists until significant remission occurs.

Patients with a history of suicide-related events, or those exhibiting a significant degree of suicidal ideation prior to commencement of treatment are known to be at greater risk of suicidal thoughts or suicide attempts and should receive careful monitoring during treatment.

  • Alzac must be discontinued in patients who start having seizures.
  • Psychosis and mood shift towards manic phase have been reported which may require discontinuation of treatment.

Pack: Box of 10 capsules

 

Price :
  Add To Cart
Back